(ĐTĐ) – The US Food and Drug Administration (FDA) has approved gabapentin enacarbil (Horizant, GlaxoSmithKline) extended-release tablets for the management of postherpetic neuralgia in adults. The drug, approved in April 2011 for the treatment of restless legs syndrome (RLS), is now approved to treat postherpetic neuralgia (PHN) at a dose of 600 mg twice […]
